Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme RDH12 plays a role in vision and retinal disease, with mutations leading to early onset visual loss and blindness, but the exact disease mechanism is unclear and there are no treatments yet.

New SRD5A2 variants may disrupt protein function, aiding diagnosis and treatment of related disorders.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Dutasteride potentially improves cell survival and reduces retinal damage in retinitis pigmentosa.

Different harmful mutations in the CDH3 gene cause HJMD, but symptoms vary among individuals.

Blocking CISD1 reduces hearing loss from cisplatin in mice.

Farudodstat may effectively treat alopecia areata by protecting hair follicles without harmful effects.

AQB reduces harmful skin changes in systemic sclerosis.

Gene therapy has potential as a future treatment for Hutchinson-Gilford progeria syndrome.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

An infant with Hutchinson-Gilford Progeria Syndrome had successful surgery to fix breathing issues caused by a new genetic mutation.

Most Hairless gene mutations reduce its ability to work with the Vitamin D Receptor, which might explain a certain type of hair loss.

Certain genetic variants reduce enzyme activity, contributing to non-classic congenital adrenal hyperplasia.

Vitamin D receptor can control the hairless gene linked to hair loss even without vitamin D.

A new DSG4 gene mutation causes hair defects in a young girl.

Notch1 signaling is impaired in hidradenitis suppurativa, affecting skin and hair cells.

A defective protein in progeria causes cell death and atherosclerosis, but a treatment targeting cell stress may reduce these effects.

Hesperidin protects rat testicles from finasteride damage and improves sperm health.

DNMT1 may help treat hypospadias by improving cell function and preventing unwanted cell changes.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Tofacitinib effectively improved severe skin symptoms in a patient with Hypohidrotic Ectodermal Dysplasia.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Targeting the Smoothened receptor shows promise for treating certain cancers.

Farudodstat may help treat alopecia areata by protecting hair follicles.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Consider rare forms of CAH for accurate diagnosis and treatment.

Nirogacestat can cause severe skin issues like hidradenitis suppurativa.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

Using SNP array testing helped quickly find the gene causing Woodhouse-Sakati syndrome in two related individuals.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.